Key result
Elevated troponin was independently associated with increased one-year mortality in patients with acute coronary syndromes (adjusted OR 1.78; 95% CI 1.30-2.44; P<0.001).
Why the study?
Does elevated troponin provide better prognostic information for one-year mortality than CK/CK-MB in patients with acute coronary syndromes?
Population
3,138 patients with acute coronary syndromes who had both CK and Tn measurements during the first 24 h of…
Comparison
Elevated troponin (Tn) levels vs Normal troponin levels, and elevated vs normal…
Design
Cohort
Follow-up
one year
Authors
Loading...
Elevated troponin signals higher one-year mortality risk in ACS; supports further biomarker research but leaves comparative value versus CK/CK-MB open.
Observational (n=3,138)
Yes
Does elevated troponin provide better prognostic information for one-year mortality than CK/CK-MB in patients with acute coronary syndromes?
Odds Ratio: 1.78 (95% CI 1.3–2.44)
p-value: p=<0.001
Elevated troponin is an independent predictor of one-year mortality in ACS patients, whereas CK/CK-MB does not provide incremental prognostic value, supporting the preferential use of troponin for risk stratification.
Yan et al. (2004) conducted an observational in Acute coronary syndromes (n=3,138). Elevated troponin vs. Normal troponin was evaluated on One-year mortality (adjusted OR 1.78, 95% CI 1.30-2.44, p=<0.001). Elevated troponin was independently associated with increased one-year mortality in patients with acute coronary syndromes (adjusted OR 1.78; 95% CI 1.30-2.44; P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: